Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,915.00    -10.00 (-0.52%)
Bid:
1,910.00
Ask:
1,945.00
Spread: 35.00 (1.832%)
Market Cap: £232.69m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

Trading Statement

11 Dec 2025 07:00

RNS Number : 0875L
S & U PLC
11 December 2025
Β 

11 December 2025

S&U plc

("S&U" or "the Group")

TRADING STATEMENT

S&U PLC (LSE: SUS), the specialist motor and property finance lender today issues its trading update for the period 5th August 2025 to 10th December 2025.

Β 

Business Highlights

Β 

The turnaround in S&U's fortunes, predicted in our last trading statement of early August, and confirmed at our interim results in October, continues apace. Group profit at the end of the third quarter continues to beat budget. Trading, particularly at Advantage, our motor finance business, is healthy both in terms of new business volumes and quality. As a result, group net receivables, the life blood of future profitability, now stand at c.Β£491 m (2024: Β£447 m) and are accelerating month by month.

Β 

This surge clearly confirms the abilities of our businesses, once freed from the shackles of regulatory intervention. The lifting of the FCA's s166 process at Advantage in April, and the calming effect that the Supreme Court's sensible decisions on commission disclosure in early August have had on the wider industry, presage a firmer motor finance market. Indeed, the latest Finance and Leasing Association statistics show the used car finance market up by 6% in September, having declined slightly by 2% in the preceding months.

Β 

By comparison, the performance of both Advantage and Aspen has been remarkably resilient given the chaotic and monumentally mishandled recent budget, and its dampening effect on consumer confidence in general and more specifically on the housing market. Ironically, a happy consequence now appears to be a dawning realisation within the Treasury and the FCA that without growth and greater access to credit, consumer satisfaction and protection are pretty hypothetical.

Β 

Advantage Finance

The last four months have seen an upsurge in trading at Advantage, led by CEO Karl Werner. Recent monthly agreement volumes have averaged 2,500, or over Β£25m in value compared to 7,121 deals in the first half. Advantage's third quarter, to the 31st of October, saw a record 869,000 finance applications, and now receivables are a net c.Β£318m, an increase of 14% on the previous quarter.

Β 

This has given Advantage the opportunity to both improve its interest margins, especially amongst higher tier customers and, with a renewed scorecard and updated affordability measures, also improve the quality of its loan book. As a result, latest collection rates for November are at a record 93.4% of due. Recency statistics on collections are at their best level for two years. The very compliant way in which Advantage manages and guides its customers who fall into arrears is shown by the most recent figures on the number and size of successful repayment arrangements. In this way Advantage can assist its customers to protect and improve their credit ratings - an attribute too little recognised in the non-prime market.

Β 

We would encourage the Financial Conduct Authority to remember this when addressing industry concerns about its Commission Redress scheme which is currently under consultation. Advantage is only tangentially affected by this commission debate, having never employed discretionary commission

Β 

("DCAs"); or tied arrangements; Advantage estimates that only 2.4% of its customers even potentially qualify for redress consideration under the proposed rules. Nevertheless, in conjunction with the Finance and Leasing Association, Advantage has produced a comprehensive and constructive response to the FCA, which proposes reductions in scope of redress and a much more focused and efficient process.

Β 

Whatever the outcome, the company anticipates that the effect of commission redress upon Advantage's current robust trading performance will be minimal. Its strong rebound should continue unabated.

Β 

Aspen Bridging

Β 

Despite the drag on transactions in the residential property market caused by the government prevarication mentioned earlier, Aspen continues to sensibly grow its loan book. At half year net receivables stood at Β£148m. At the end of the period under review these are now c.Β£173m.

Β 

Repayments in the period were at Β£47m and year to date they are ahead of budget at Β£160m. Advances in the period were Β£75m, driven by a greater number of smaller deals for bridging products augmented by our very popular Buy to Let loans the average size of which is over Β£1.3m. Margins are stable and on budget. Application numbers were inevitably affected by drawn out budget speculation and then imposition of higher taxes on rental incomes, council tax extensions and a new mansion tax; however, these have rebounded in the last three weeks.

Β 

The quality of Aspen's loan book also remains good with just 16 out of 240 loans beyond term. Aspen is making steady progress on resolving the very small number of longer-term cases.

Β 

Although it is to be hoped that lower interest rates will produce a significant but unlikely revival in the UK's hidebound residential market, Aspen will nevertheless produce a solid second half and another good profit for the year as a whole.

Β 

Funding

Β 

The very welcome acceleration in activity throughout the Group of the past few months has seen Group net borrowings rise to Β£241m from Β£180m at the half year. Whilst the existing funding capacity of Β£280m will meet our requirements for the immediate future, an exciting project is at present under way to confirm substantially larger, but flexible, medium-term facilities on a competitive basis. These will facilitate the expansion we foresee for both businesses over the next three years.

Β 

Commenting on S&U's trading outlook, Anthony Coombs, S&U Chairman, said:

"Recent months have undoubtedly confirmed that S&U has regained its "Va Va Voom"; to quote my predecessor's habitual phrase. It is also true that investors are increasingly aware of the value inherent in family-controlled SME businesses with rewarding dividend policies. With both Advantage and Aspen on the right track, we have every confidence in the good rewards for shareholders we anticipate in the years to come".

Β 

Β 

Β 

Β 

Β 

For further information, please contact:

Enquiries

Anthony Coombs

S&U plc

c/o SEC Newgate

Financial Public Relations

Bob Huxford, Harry Handyside, Aqsa Ali

SEC Newgate

020 7653 9848

Broker

Andrew Buchanan, Rob Parker

Peel Hunt LLP

020 7418 8900

Broker

James Felix, John Welch, Daniel Gee-Summons

Berenberg

020 3207 7800

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTBRBDDCXBDGUG
Date   Source Headline
21st May 201012:37 pmRNSResult of AGM
21st May 20107:00 amRNSInterim Management Statement
17th May 20107:00 amRNSAnalyst Presentation
19th Apr 20104:07 pmRNSAnnual Financial Report
1st Apr 20103:38 pmRNSAnnual Information Update
24th Mar 20107:00 amRNSFinal Results
9th Feb 20107:00 amRNSTrading Update
9th Dec 20097:00 amRNSInterim Management Statement
12th Nov 200910:50 amRNSAcquisition
25th Sep 20092:08 pmRNSDirector/PDMR Shareholding
24th Sep 20097:00 amRNSHalf Yearly Report
11th Aug 20097:00 amRNSTrading Statement
20th Jul 200910:47 amRNSTransaction in Own Shares
26th Jun 20097:00 amRNSUK Scrappage Scheme Partnership
29th May 200911:37 amRNSStatement re: Annual Financial Report
26th May 20096:05 pmRNSDirector/PDMR Shareholding - Replacement
26th May 20093:00 pmRNSDirector/PDMR Shareholding
22nd May 200912:30 pmRNSResult of AGM
22nd May 20097:00 amRNSInterim Management Statement
1st Apr 20094:52 pmRNSAnnual Information Update
1st Apr 20094:52 pmRNSAnnual Information Update
31st Mar 20095:33 pmRNSDirector/PDMR Shareholding
31st Mar 20097:00 amRNSFinal Results
17th Mar 200910:00 amRNSGrowing Companies Day
19th Jan 20094:28 pmRNSDirector/PDMR Shareholding
13th Jan 20095:25 pmRNSDirector/PDMR Shareholding
10th Dec 20087:00 amRNSInterim Management Statement
29th Sep 20085:03 pmRNSDirector/PDMR Shareholding
25th Sep 20087:00 amRNSInterim Results
5th Sep 20083:45 pmRNSDirectorate Change
24th Jun 20087:00 amRNSChange of Adviser
20th Jun 20083:54 pmRNSDirector/PDMR Shareholding
18th Jun 20088:00 amRNSInterim Management Statement
29th May 20083:35 pmRNSAnnual Report and Accounts
16th May 200812:35 pmRNSResult of AGM
17th Apr 20084:31 pmRNSDirector/PDMR Shareholding
30th Jan 20085:34 pmRNSDirector/PDMR Shareholding
6th Dec 20078:00 amRNSInterim Management Statement
22nd Nov 20075:32 pmRNSDirector/PDMR Shareholding
27th Sep 20078:00 amPRNHalf-yearly Report
6th Aug 20073:14 pmRNSDirector/PDMR Shareholding
20th Jun 20073:11 pmRNSInterim Management Statement
21st May 200710:04 amRNSDirector/PDMR Shareholding
18th May 200712:15 pmRNSDirectorate Change
18th May 200712:07 pmRNSAGM Statement
30th Mar 200710:14 amRNSDirector/PDMR Shareholding
29th Mar 20078:00 amPRNPreliminary Announcement January 2007 Results
27th Mar 20071:08 pmRNSPrelim Results Release Date
22nd Dec 200612:14 pmRNSTotal Voting Rights
1st Jun 200610:58 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.